Health & Life Co., Ltd.
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
Health & Life Co., Ltd. (1781) - Total Assets
Latest total assets as of September 2025: NT$656.14 Million TWD
Based on the latest financial reports, Health & Life Co., Ltd. (1781) holds total assets worth NT$656.14 Million TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Health & Life Co., Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how Health & Life Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Health & Life Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Health & Life Co., Ltd.'s total assets of NT$656.14 Million consist of 71.1% current assets and 28.9% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 27.8% |
| Accounts Receivable | NT$139.00 Million | 17.0% |
| Inventory | NT$130.48 Million | 16.0% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Health & Life Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Health & Life Co., Ltd.'s current assets represent 71.1% of total assets in 2024, a decrease from 74.2% in 2021.
- Cash Position: Cash and equivalents constituted 27.8% of total assets in 2024, up from 25.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 17.0% of total assets.
Health & Life Co., Ltd. Competitors by Total Assets
Key competitors of Health & Life Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Health & Life Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Health & Life Co., Ltd. generates 0.86x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Health & Life Co., Ltd. generates $ 2.97 in net profit.
Health & Life Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.25 | 2.32 | 2.32 |
| Quick Ratio | 2.45 | 1.81 | 1.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$298.92 Million | NT$ 347.56 Million | NT$ 347.56 Million |
Health & Life Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Health & Life Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.72 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 15.0% |
| Total Assets | NT$817.26 Million |
| Market Capitalization | $12.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values Health & Life Co., Ltd.'s assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Health & Life Co., Ltd.'s assets grew by 15.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Health & Life Co., Ltd. (2021–2024)
The table below shows the annual total assets of Health & Life Co., Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$817.26 Million | +14.98% |
| 2023-12-31 | NT$710.79 Million | -11.12% |
| 2022-12-31 | NT$799.76 Million | +3.01% |
| 2021-12-31 | NT$776.39 Million | -- |